MedPath

ALPHABET study (ALPHABET study)

Not yet recruiting
Conditions
Overactive bladder with benign prostatic hyperplasia
Registration Number
jRCT1011230058
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
60
Inclusion Criteria

Age over 40 Prostate volume less than 30ml OAB Postvoid residual less than 100ml Patients who agree with the research

Exclusion Criteria

Postvoid residual over 100ml suspected of prostate cancer any medicationfor LUTS within 8 weeks patients with neurogenic disease patients with active urinary infection patients with hypotension patients with severe heart disease patients with severe liver disease pateints with severe kidney disease patients with allergy with tamsulocin/vibegron

Study & Design

Study Type
Interventional
Study Design
crossover assignment
Primary Outcome Measures
NameTimeMethod
-

OABSS

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.